Unlock instant, AI-driven research and patent intelligence for your innovation.
Pharmaceutical composition for curing rheumatoid arthritis
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A rheumatoid and arthritis technology, applied in the direction of drug combination, effective ingredients of hydroxyl compounds, antipyretics, etc., can solve the problems of drug resistance and side effects
Active Publication Date: 2010-01-06
JILIN ZIXIN PHARMA
View PDF0 Cites 3 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0003] At present, many antibiotics and chemical drugs are used in the drug treatment of rheumatoid arthritis, but it is difficult to treat due to drug resistance and side effects, especially the ideal drug that can effectively control the development of the disease, have less side effects, and reduce the recurrence of the disease , yet to be developed
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0095] 14g of β-eucalyptol, 12g of anhysterone, 30g of total alkaloids of Phellodendron Phellodendri, 30g of coix seed alcoholic extract.
[0096] The extracts are mixed, and the conventional excipients for tablet preparation are added, and pressed into tablets to make tablets.
[0097] The above-mentioned various extracts in the present invention can be obtained by any extraction method in the prior art, preferably:
[0098] β-eucalyptol: Weigh an appropriate amount of raw materials, reflux and extract with distilled water for 1-3 times, add 7-15 times of distilled water each time, boil for 1-3 hours and filter, combine the filtrates, and concentrate.
[0099] Achyrantheterone: Weigh an appropriate amount of raw materials, decoct 1-3 times with water, add 6-17 times of water each time and decoct for 0.5-3 hours, filter and combine the filtrate, and concentrate.
[0100] PhellodendronPhellodendron total alkaloids: Weigh an appropriate amount of raw materials, extract 1-3 tim...
Embodiment 2
[0103] 22g of β-eucalyptol, 21g of anhysterone, 40g of total alkaloids of Phellodendron Phellodendri, 40g of coix seed alcoholic extract.
[0104] Add the conventional adjuvant 477g that prepares pill, make 100 balls, every ball 6g.
Embodiment 3
[0106] 30g of β-eucalyptol, 30g of anhysterone, 50g of total alkaloids of Cortex Phellodendri, 50g of coix seed alcoholic extract.
[0107] Add conventional excipients for preparing granules, and granulate.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention relates to a pharmaceutical composition for curing rheumatoid arthritis, belonging to traditional Chinese medicines. The pharmaceutical composition comprises the following active materials in percentage by weight: 14-30 beta-eucalyptol, 12-30 inocosterone, 30-50 phellodendron total alkaloid and 30-50 coix seed alcohol extract, is used for curing symptoms, such as the damp invasion of lower energizer, foot and knee inflammation, muscle and joint pain, and the like and has the actions of clearing heat and promoting diuresis.
Description
technical field [0001] The invention belongs to traditional Chinese medicine, in particular to a pharmaceutical composition for treating rheumatoid arthritis. Background technique [0002] Rheumatoid arthritis is a personal disease mainly characterized by non-suppurative inflammation of joints and periarticular tissues, often accompanied by extra-articular symptoms, so it is called rheumatoid. Synovial inflammation in the joint cavity, exudate, cell proliferation, granuloma formation, cartilage and bone tissue destruction, and finally joint ankylosis and dysfunction. It often invades small joints, such as hands, feet, and wrist joints. It is often symmetrical and has a chronic course. There may be temporary relief. Due to multi-system damage, autoantibodies can be found in the serum, so the disease is considered to be an autologous disease. . Traditional Chinese medicine believes that rheumatoid arthritis syndrome should be rheumatism-heat numbness, which is a syndrome cau...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More